In this study, we compared the efficacy of 3 different protocols administered during cesarean delivery in pregnant women at high risk for PPH: oxytocin alone (Group 1), oxytocin + rectal misoprostol (Group 2), and oxytocin + intrauterine misoprostol (Group 3). The gene discussed is OXT; the disease is pulmonary arterial hypertension.